Related Experiment Video

Updated: Aug 14, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Mithramycin A activates Fas death pathway in leukemic cell lines

I Leroy1, G Laurent, A Quillet-Mary

  • 1INSERM U563/CPTP, Toulouse, France.

Apoptosis : an International Journal on Programmed Cell Death
|December 24, 2005
PubMed

Insights

Mithramycin A induces cancer cell death by activating the Fas apoptotic pathway, independent of Fas ligand. This mechanism enhances sensitivity to chemotherapy, offering potential clinical benefits.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Mithramycin A (MMA) is known to induce apoptosis.
  • The Fas apoptotic pathway is crucial for anticancer drug efficacy.
  • MMA's precise role in Fas signaling was not fully elucidated.

Purpose of the Study:

  • To investigate the effect of Mithramycin A on the Fas apoptotic signaling pathway.
  • To determine if MMA-induced apoptosis is mediated through Fas signaling.
  • To explore MMA's potential to sensitize cancer cells to chemotherapy.

Main Methods:

  • Treatment of Fas-sensitive Jurkat and Fas-resistant KG1a cells with Mithramycin A.
  • Analysis of Fas clustering, DISC formation, and caspase cleavage.
  • Assessment of c-Flip(L) expression levels.
  • Evaluation of MMA's effect on chemosensitization.

Main Results:

  • Mithramycin A induced apoptosis in both Fas-sensitive and Fas-resistant cell lines.
  • MMA triggered Fas clustering, DISC formation, and caspase cleavage, indicating Fas pathway activation.
  • This activation was independent of Fas ligand binding.
  • Modulation of c-Flip(L) expression correlated with MMA-induced Fas pathway activation.
  • Sub-lethal MMA doses sensitized KG1a cells to chemotherapeutic agents.

Conclusions:

  • Mithramycin A activates the Fas apoptotic pathway, leading to cancer cell death.
  • MMA's mechanism involves Fas clustering, DISC formation, and caspase activation, independent of Fas ligand.
  • MMA modulates c-Flip(L) expression and sensitizes cells to chemotherapy, suggesting clinical applications.

More Related Videos

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...